1.230CAD0.00%Mkt Cap: 126.10M $P/E: —1d ago
Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vap…
Industry Peers
Drug Manufacturers - Specialty & GenericIndicators:|
Key Statistics
Company
Market Cap126.10M $
Enterprise Value167.33M $
Revenue (TTM)199.68M $
Gross Profit65.70M $
Net Income (TTM)-18.03M $
Revenue/Share1.483 USD
Last Price1.230 CAD
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees1.1K
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA68620P1018
Valuation
P/E (Trailing)—
P/E (Forward)41.00
PEG—
EV/EBITDA75.43
EV/Revenue0.84
P/S0.63
P/B0.45
EPS (TTM)-0.21
EPS (Forward)0.03
52W Range
1.1952% of range3.090
52W High3.090 CAD
52W Low1.195 CAD
Profitability
Gross Margin34.81%
Oper. Margin-16.38%
EBITDA Margin1.11%
Profit Margin-9.55%
ROE-7.09%
ROA-4.40%
Growth
Revenue Growth-8.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.53M $
CapEx (TTM)12.42M $
FCF Margin5.87%
FCF Yield9.30%
Net Debt2.25M $
Net Debt/EBITDA1.02
Balance Sheet
Debt/Equity0.03
Current Ratio2.82
Quick Ratio0.66
Book Value/Sh2.725 CAD
Cash/Share0.0360 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:4
Split DateJul 7, 2023
Analyst Consensus
Rating—
Target (Mean)2.980 CAD
Upside (mean)+142.3%
Target Range1.650 CAD – 4.000 CAD
CAD1.650+142.3% to meanCAD4.000
# Analysts5
Ownership
Shares Out.140.78M
Float98.21M
Insiders30.26%
Institutions6.55%
Short Interest
Short Ratio15.8d
Short % Out.1.57%
Shares Short2.23M
Short (prev mo.)2.07M
Technical
SMA 501.484 (-17.1%)
SMA 2002.006 (-38.7%)
Beta1.85
S&P 52W Chg19.63%
Avg Vol (30d)213.07K
Avg Vol (10d)374.25K
Technical Indicators
RSI (14)27.0
MACD-0.0661
MACD Signal-0.0541
MACD Hist.-0.0120
BB Upper1.516 CAD
BB Middle1.370 CAD
BB Lower1.223 CAD
BB Width21.39%
ATR (14)0.0616 CAD
Vol Ratio (20d)1.35x